Find and Pitch Jounalists, Get Your Story Covered

Tags: hardware robotics startups funding industrial robotics

	Profile	Recent Articles on Subject
1	Michael Gibney Pharma Voice	Biopharma’s FTC headache deepens with guideline shifts years in the making - 5 months ago Real Chemistry’s CEO on biopharma’s outlook in 2024 - 5 months ago The thorniest questions facing pharma, according to a leading bioethicist - 6 months ago How Big Pharma keeps the oncology engines hot with a host of strategies - 6 months ago The PharmaVoice 100: Rare disease warriors - 7 months ago The PharmaVoice 100: Trailblazers - 8 months ago
2	Nicholas Florko STAT News Reports on US health business. Washington, DC healthcarepolicy	STAT+: Medical marijuana companies are using pharma’s sales tactics with little of the same scrutiny - 5 months ago
3	Kelly Bilodeau Pharma Voice Mom, wife, freelance writer. writing	What are pharma’s next blockbusters? - 5 months ago Oncology drugmakers seek the sweet spot between efficacy and tolerability - 5 months ago Patient groups have become a powerhouse in R&D. Here’s a look at their impact. - 7 months ago From the rainforest to Wall Street — Jaguar Health’s big play for revitalization - 7 months ago
4	Seema Verma Pharma Voice	Trends shaping the pharmaceutical industry in 2024 - 5 months ago
5	SVP and GM Pharma Voice	Trends shaping the pharmaceutical industry in 2024 - 5 months ago
6	Oracle Life Sciences Pharma Voice	Trends shaping the pharmaceutical industry in 2024 - 5 months ago
7	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Up and down the ladder: The latest comings and goings - 5 months ago STAT+: Pharmalittle: Sanofi scraps rare-disease drug deal under FTC pressure; patients regain weight after stopping Lilly’s Zepbound - 5 months ago STAT+: Up and down the ladder: The latest comings and goings - 5 months ago STAT+: Pharmalittle: Pfizer is leaving the BIO trade group; CVS drug-pricing plan may not lower costs for consumers - 5 months ago STAT+: Up and down the ladder: The latest comings and goings - 6 months ago STAT+: Pharmalittle: Bioscience job market is upside down; Sanofi and Regeneron’s blockbuster Dupixent may find bigger market - 6 months ago STAT+: More drug and device patents were invalidated for bad info than those filed by other industries, analysis finds - 6 months ago STAT+: Up and down the ladder: The latest comings and goings - 6 months ago STAT+: Pharmalittle: FTC challenges ‘inaccurately or improperly’ listed patents; Elliott builds stake in BioMarin - 6 months ago STAT+: Pharmalittle: Pharma trade group slams European Commission proposal; U.S. lawmakers demand FDA explain its approach to shortages - 6 months ago STAT+: Up and down the ladder: The latest comings and goings - 6 months ago STAT+: Up and Down the Ladder: The latest comings and goings - 7 months ago STAT+: Pharmalittle: Sanofi plans to spin off its consumer health biz; EMA says no evidence GLP-1 drugs linked to thyroid cancer - 7 months ago STAT+: Pharmalittle: Pharma moves closer to a pricing deal with U.K.; FDA to review AstraZeneca request for self-administered flu vax - 7 months ago STAT+: Up and down the ladder: The latest comings and goings - 7 months ago STAT+: Pharmalittle: Weight-loss drugs fuel boom for firms that fill syringes; employers that cover obesity drug may double in 2024 - 7 months ago STAT+: Up and down the ladder: The latest comings and goings - 7 months ago STAT+: Up and down the ladder: The latest comings and goings - 8 months ago STAT+: Pharmalittle: More than 9 in 10 pharmacy techs report drug shortages; Yale and VA strike deal over ketamine patent royalties - 8 months ago
8	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	FDA chastens pet companies over antibiotics - 5 months ago
9	Catherine Owen Pharmaceutical Executive	Embracing the Future: Meeting Doctors and Patients Where They Are Now - 5 months ago
10	Rachel Cohrs STAT News Washington Correspondent @statnews. Washington, DC health policyjournalism	STAT+: Pfizer plans to depart BIO - 5 months ago

Journalists covering pharmaceutical industry